COMMUNIQUÉS West-GlobeNewswire

Sientra to Participate in Upcoming Investor Conferences
31/10/2018
SANTA BARBARA, Calif., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN), a medical aesthetics company, announced today that members of management are scheduled to participate in three upcoming investor [...]
Cerecor Announces Submission of Three Orphan Drug Designation Requests for Substrate Replacement Therapies to treat Congenital Disorders of Glycosylation
31/10/2018
BALTIMORE, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare and orphan diseases in [...]
CV Sciences, Inc. to Host Third Quarter 2018 Financial Results Conference Call on Wednesday, November 7, 2018
31/10/2018
LAS VEGAS, Oct. 31, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI), preeminent supplier and manufacturer of industry leading hemp extract brand, PlusCBD Oil™ , announced that it is scheduled to host a [...]
Soricimed Publishes New Research Validating TRPV6 as a Therapeutic Target for Ovarian Cancer
31/10/2018
MONCTON, New Brunswick, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Soricimed Biopharma Inc. ("Soricimed"), a clinical-stage pharmaceutical company discovering and developing targeted cancer therapeutics, is pleased to announce [...]
Ira Duarte Promoted to Chief Financial Officer of Veloxis Pharmaceuticals A/S
31/10/2018
Company Release no. 18/2018 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 31 October 2018 Ira Duarte Promoted to Chief Financial Officer of Veloxis Pharmaceuticals A/S Veloxis Pharmaceuticals A/S (NASDAQ: VELO) today [...]
Tabula Rasa HealthCare to Participate in Upcoming Investor Conference
31/10/2018
MOORESTOWN, N.J., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, today announced that Chairman and CEO, [...]
Eurobio Scientific : LEVEE DE FONDS OBLIGATAIRE D'UN MONTANT DE 2,5 M€ AVEC VATEL DIRECT
31/10/2018
LEVEE DE FONDS OBLIGATAIRE D'UN MONTANT DE 2,5 M€ AVEC VATEL DIRECT Eurobio Scientific et Vatel Direct clôturent avec succès une nouvelle levée de fonds obligataire de 2,5 M€ pour financer de potentielles acquisitions [...]
Sandoz receives US FDA approval for biosimilar Hyrimoz(TM) (adalimumab-adaz)
31/10/2018
Biosimilar Hyrimoz TM (adalimumab-adaz) approved for all indications of reference medicine not protected by orphan exclusivity ** Biosimilars are critical to sustaining US healthcare system, providing broader access to [...]
Change to Executive Management: Anders Hedegaard leaves as CEO of GN Hearing
31/10/2018
Anders Hedegaard has decided to resign as CEO of GN Hearing. Marcus Desimoni will act as interim CEO of GN Hearing, in parallel with his role as CFO of GN Store Nord and GN Hearing, until a new CEO of GN Hearing is [...]
Orion Biotechnology Completes Scientific Advice Meeting with MHRA
31/10/2018
OTTAWA, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a developer of novel medical treatments, announced today the completion of a scientific advice meeting with the Medicines and Healthcare [...]
NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Technology
31/10/2018
WALTHAM, Mass., Oct. 31, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 10,112,040 titled “Transcutaneous electrical nerve [...]
Trogarzo® Phase III Data Analysis featured During Late-Breaking Oral Presentation at HIV Drug Therapy Glasgow 2018
31/10/2018
MONTRÉAL, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) announced that additional analysis of phase III clinical trial data of Trogarzo ® (ibalizumab-uiyk) injection was [...]
Analyse des données de phase III de Trogarzo® présentée lors d’une présentation orale de dernière heure à HIV drug therapy Glasgow 2018
31/10/2018
MONTREAL, 31 oct. 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) annonce qu’une analyse additionnelle des données de l’étude clinique de phase III de Trogarzo MD (ibalizumab-uiyk) [...]
Novo Nordisk A/S: Share repurchase programme
31/10/2018
Bagsværd, Denmark, 31 October 2018 - On 10 August 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 [...]
Southlake Radiology Deploys Speech Recognition and Secure Healthcare Communication Platform from eRAD
31/10/2018
Tools make a difference in referring provider relationships GREENVILLE, S.C., Oct. 31, 2018 (GLOBE NEWSWIRE) -- eRAD announced today that Southlake Radiology has implemented eRAD Speech Recognition and RADAR, eRAD’s [...]
Asterias Biotherapeutics Announces Positive Outcome from Data Review from OPC1 Spinal Cord Injury Study
31/10/2018
Meeting with Food and Drug Administration Remains on Track for End of 2018 FREMONT, Calif., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE American: AST), a biotechnology company dedicated to [...]
Progentec Diagnostics, Inc. Raises Funds to Support Advances in Lupus Detection and Management
31/10/2018
New funding brings lupus-detection tools closer to commercialization Acquisition of LupusCorner marks a step forward in developing a first-in-class lupus-management platform OKLAHOMA CITY, Oct. 31, 2018 (GLOBE NEWSWIRE [...]
DLT Resolution Launches DLT Internet Assurance (Automatic Failover) - Wireless Redundancy for Broadband Clients
31/10/2018
Las Vegas, NV, Oct. 31, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- DLT Resolution Inc. (OTC: DLTI), a Distributed Ledger Technology (“Blockchain”) and Information Technology company, is pleased to announce the launch [...]
Ritter Pharmaceuticals Announces Agreement for $6.0 Million At-Market Private Placement of Series B Convertible Preferred Stock and Warrants
31/10/2018
LOS ANGELES, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of novel therapeutic products that modulate the gut microbiome to treat [...]

Pages